| Study ID/Title |
Condition |
Description |
| M11-290 |
| A study to learn how effective and safe a medicine called adalimumab works to treat children with moderate to severe ulcerative colitis |
Ulcerative colitis |
Trial dates:
Oct 2014 - Feb 2020
Last modified:
Mar 2021
Available languages:
English, Spanish,
Dutch, Slovakian,
Japanese, Polish
|
| M11-327 |
| A study to learn how well and safe long-term use of a medicine called adalimumab works to treat adult patients with non-infectious intermediate uveitis, posterior uveitis, or panuveitis |
Uveitis |
Trial dates:
Dec 2010 – May 2018
Last modified:
Jul 2019
Available languages:
English, German,
Italian, Japanese,
Polish, Spanish
|
| M14-033 |
|
|
| A study to learn how effective and safe higher doses of the study drug adalimumab is for patients with ulcerative colitis |
Ulcerative colitis |
Trial dates:
Mar 2014 - Nov 2019
Last modified:
Oct 2020
Available languages:
English, Dutch,
Italian, Spanish,
Japanese, Polish,
Ukrainian
|
| M14-115 |
A study to learn how effective and safe a medicine containing the study drug adalimumab works to treat patients with moderate to severe Crohn’s disease
|
Crohn's Disease |
Trial dates:
May 2014 - Jan 2020
Last modified:
Feb 2021
Available languages:
English, Polish,
Dutch, Ukrainian,
Hebrew, Czech
|
| M14-496 |
| A study to learn how effective and safe adalimumab is compared to methotrexate in the treatment of adult patients with psoriatic arthritis |
Psoriatic arthritis |
Trial dates:
Aug 2016 - Mar 2020
Last modified:
Mar 2021
Available languages:
English, Polish,
Portuguese, Czech,
Spanish, Bulgarian
|
| M14-500 |
A study to learn if clinical disease activity measured by Magnetic Resonance Imaging (MRI) helped predict flares in adult patients with rheumatoid arthritis in remission who were being treated with dose-tapered adalimumab
|
Rheumatoid arthritis |
Trial dates:
Jan 2015 – Aug 2018
Last modified:
Oct 2019
Available languages:
English, German,
Italian, Spanish
|
| M15-574 |
| A study to learn how effective and safe the study drug adalimumab is for patients with hidradenitis suppurativa |
Hidradenitis suppurativa |
Trial dates:
Jul 2016 - Oct 2019
Last modified:
Aug 2020
Available languages:
English, Dutch,
German, Greek,
Spanish, Turkish
|
| M15-989 |
| A study to learn how safe a medicine containing the study drug risankizumab is for patients with moderate to severe Crohn's disease |
Crohn's Disease |
Trial dates:
Sep 2015 – Jun 2019
Last modified:
May 2020
Available languages:
English, Dutch,
Korean, Spanish,
German, Polish
|
| M15-992 |
| A study to learn how effective and safe a medicine containing the study drug risankizumab is compared to placebo (no medicine) to treat adult patients with moderate to severe long-lasting plaque psoriasis after initial treatment, withdrawal, relapse, and re-treatment |
Psoriasis |
Trial dates:
Feb 2016 – Jul 2018
Last modified:
Sep 2019
Available languages:
English, French,
French Canadian,
German, Japanese,
Korean
|
| M15-999 |
| A study to learn how effective and safe a new formulation of risankizumab is compared to placebo (no medicine) for patients with moderate to severe plaque psoriasis |
Psoriasis |
Trial dates:
May 2019 - Jul 2020
Last modified:
Apr 2021
Available languages:
English, Spanish
|
| M16-004 |
| A study to learn how effective and safe a medicine containing the study drug risankizumab works compared to placebo (no medicine) to treat adult Japanese patients with moderate to severe long-lasting plaque psoriasis |
Psoriasis |
Trial dates:
Dec 2016 – Jun 2018
Last modified:
Aug 2019
Available languages:
English, Japanese
|
| M16-005 |
| A study to learn how effective and easy-to-use a medicine called risankizumab is for patients with moderate to severe plaque psoriasis |
Psoriasis |
Trial dates:
Jun 2019 - Aug 2020
Last modified:
Jun 2021
Available languages:
English
|
| M16-009 |
A study to learn how effective and safe a medicine containing the study drug risankizumab works to treat adult patients with moderate to severe long-lasting plaque psoriasis
|
Psoriasis |
Trial dates:
Nov 2014 – Sep 2018
Last modified:
Jul 2019
Available languages:
English, French,
French Canadian,
German
|
| M16-048 |
| A study to learn how safe and effective a medicine containing the study drug upadacitinib works compared to placebo (no medicine) to treat adult patients with moderate to severe atopic dermatitis |
Atopic dermatitis |
Trial dates:
Oct 2016 – Jan 2019
Last modified:
Apr 2020
Available languages:
English, Finnish,
Dutch, Japanese,
German
|
| M16-063 |
A study to learn how effective and safe elsubrutinib taken by itself or in combination with upadacitinib works to treat adult patients with rheumatoid arthritis compared to placebo
|
Rheumatoid arthritis |
Trial dates:
Oct 2018 - Mar 2020
Last modified:
Mar 2021
Available languages:
English, Czech,
Dutch, Hungarian,
Polish, Spanish
|
| M16-176 |
A study to learn how effective and safe a medicine containing the study drug risankizumab is compared to placebo (no medicine) to treat adult patients with moderate to severe plaque psoriasis
|
Psoriasis |
Trial dates:
Jul 2018 - Dec 2019
Last modified:
Jan 2021
Available languages:
English, Russian
|
| M16-178 |
| A study to learn how effective and safe a medicine containing the study drug risankizumab works compared to the study drug FUMADERM® to treat adult patients with moderate to severe plaque psoriasis |
Psoriasis |
Trial dates:
Aug 2017 – Jul 2018
Last modified:
Jul 2019
Available languages:
English, German
|
| M16-244 |
|
|
| A study to learn how safe and effective a medicine containing the study drug risankizumab is for adult patients with psoriatic arthritis |
Psoriatic arthritis |
Trial dates:
Dec 2016 – Jul 2018
Last modified:
May 2020
Available languages:
English, Czech,
Finnish, Japanese,
Polish, Spanish
|
| M16-560 |
|
|
| A study to learn how effective and safe a new medicine called ABBV-3373 is when compared to adalimumab and placebo for adult patients with moderate to severe rheumatoid arthritis |
Rheumatoid arthritis |
Trial dates:
Mar 2019 - Aug 2020
Last modified:
Jun 2021
Available languages:
English, Spanish,
Hungarian, Hebrew,
Polish
|
| M16-766 |
|
|
| A study to learn how effective and safe a medicine containing the study drug risankizumab compared to secukinumab is for patients with moderate to severe plaque psoriasis |
Psoriasis |
Trial dates:
May 2018 - Jul 2020
Last modified:
Apr 2021
Available languages:
English, Dutch,
French, German,
Polish, Spanish
|
| 3030-401-002 |
|
|
| A study to learn how effective and safe a medicine called eluxadoline works to treat patients with irritable bowel syndrome with diarrhea, who may also have bile acid malabsorption |
Irritable bowel syndrome |
Trial dates:
Feb 2018 - Apr 2020
Last modified:
Mar 2021
Available languages:
English
|
| |
|---|
Oncology
|
|---|
